Safety of non-steroidal anti-inflammatory drugs during pregnancy and lactation

[1]  U. Simeoni,et al.  Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors , 2004, European Journal of Pediatrics.

[2]  I. Matheson,et al.  Piroxicam in breast milk after long-term treatment , 2004, European Journal of Clinical Pharmacology.

[3]  M. Østensen Piroxicam in human breast milk , 2004, European Journal of Clinical Pharmacology.

[4]  S. Carlan,et al.  Outpatient Oral Sulindac to Prevent Recurrence of Preterm Labor , 1995, Obstetrics and gynecology.

[5]  M. Østensen Optimisation of Antirheumatic Drug Treatment in Pregnancy , 1994 .

[6]  B. Sibai,et al.  Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy. , 1994, American journal of obstetrics and gynecology.

[7]  Jeffrey R. Wilson,et al.  CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.

[8]  D. Lewis,et al.  Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate , 1994 .

[9]  F. Witter Clinical Pharmacokinetics in the Treatment of Rheumatoid Arthritis in Pregnancy , 1993, Clinical Pharmacokinetics.

[10]  K. Moise,et al.  The Effect of Gestational Age and Fetal Indomethacin Levels on the Incidence of Constriction of the Fetal Ductus Arteriosus , 1993, Obstetrics and gynecology.

[11]  H. Madhav,et al.  Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study. , 1993, American journal of obstetrics and gynecology.

[12]  Italianstudyofaspirininpregna Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension , 1993 .

[13]  P. Merlob,et al.  NSAIDs: Maternal and Fetal Considerations , 1992, American journal of reproductive immunology.

[14]  D. Mastrogiannis,et al.  Randomized Comparative Trial of Indomethacin and Sulindac for the Treatment of Refractory Preterm Labor , 1992, Obstetrics and gynecology.

[15]  B. Luke,et al.  The Association Between Maternal Weight Gain and the Birthweight of Twins , 1992 .

[16]  K. Ilett,et al.  Excretion of indomethacin in breast milk. , 1991, British journal of clinical pharmacology.

[17]  J. Gouyon,et al.  [Neonatal kidney insufficiency and intrauterine exposure to ketoprofen]. , 1991, Archives francaises de pediatrie.

[18]  D. Wurtzel Prenatal Administration of Indomethacin as a Tocolytic Agent: Effect on Neonatal Renal Function , 1990, Obstetrics and gynecology.

[19]  J. Elliott,et al.  Oligohydramnios in each sac of a triplet gestation caused by Motrin--fulfilling Kock's postulates. , 1990, American journal of obstetrics and gynecology.

[20]  G. Greenberg,et al.  Drugs in Pregnancy and Lactation , 1990 .

[21]  S. Shapiro,et al.  The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects , 1989, The New England journal of medicine.

[22]  D. Nyberg,et al.  The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor , 1989 .

[23]  J. G. Carrasco,et al.  Anemia aguda, rectorragia y hematuria asociadas a la ingestión de naproxén , 1989 .

[24]  D S Sharif,et al.  Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. , 1988, The New England journal of medicine.

[25]  K. Rothman,et al.  Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. , 1985, The New England journal of medicine.

[26]  D. Dudley,et al.  Fetal and neonatal effects of indomethacin used as a tocolytic agent. , 1985, American journal of obstetrics and gynecology.

[27]  K. Woods MEDICARE: A NEW HEALTH INSURANCE PROGRAMME FOR AUSTRALIA , 1984, The Lancet.

[28]  F. Jamali,et al.  Naproxen excretion in milk and its uptake by the infant. , 1983, Drug intelligence & clinical pharmacy.

[29]  K. Momma,et al.  Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. , 1983, Prostaglandins.

[30]  M. Stuart,et al.  Effects of Acetylsalicylic Acid Ingestion on Maternal and Neonatal Hemostasis , 1982 .

[31]  B. Rumack,et al.  Neonatal Intracranial Hemorrhage and Maternal Use of Aspirin , 1981, Obstetrics and gynecology.

[32]  W. Wilson,et al.  A 16-Day-Old Breast-fed Infant with Metabolic Acidosis Caused by Salicylate , 1981 .

[33]  A. Wilkinson NAPROXEN LEVELS IN PRETERM INFANTS AFTER MATERNAL TREATMENT , 1980, The Lancet.

[34]  R. White,et al.  The inhibition of premature labor with indomethacin. , 1980, American journal of obstetrics and gynecology.

[35]  M. Mitchell,et al.  Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen. , 1979, Archives of disease in childhood.

[36]  F. Raucci,et al.  [Use of ketoprofen in threatened preterm labor]. , 1979, Minerva ginecologica.

[37]  O. Eeg‐Olofsson,et al.  CONVULSIONS IN A BREAST-FED INFANT AFTER MATERNAL INDOMETHACIN , 1978, The Lancet.

[38]  R. L. Jordan,et al.  Indomethacin: studies of absorption and placental transfer. , 1977, American journal of obstetrics and gynecology.

[39]  J. Tourville Birth Defects and Drugs in Pregnancy , 1977 .

[40]  S. Shapiro,et al.  ASPIRIN AND CONGENITAL MALFORMATIONS , 1976, The Lancet.

[41]  G. Turner,et al.  MATERNAL EFFECTS OF REGULAR SALICYLATE INGESTION IN PREGNANCY , 1975, The Lancet.

[42]  G. Turner,et al.  FETAL EFFECTS OF REGULAR SALICYLATE INGESTION IN PREGNANCY , 1975, The Lancet.

[43]  G. Levy,et al.  Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium , 1975, Clinical pharmacology and therapeutics.

[44]  H. Zuckerman,et al.  Inhibition of Human Premature Labor by Indomethacin , 1974, Obstetrics and gynecology.

[45]  J. Schulman,et al.  Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. , 1973, Lancet.

[46]  I. Pless,et al.  West Indian one-year-olds. A comparative analysis of health and service utilisation. , 1967, Lancet.